The iXCELL-DCM Trial: Rationale and Design.

Henry TD, Schaer GL, DeMaria A, Recker D, Remmers AE, Goodrich J, Patel A.  The iXCELL-DCM Trial: Rationale and Design.  Cell Transplant. 2016 Mar 22. [Epub ahead of print].  DOI:10.3727/096368916X691295.

Read More

A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction

Povsic TJ, O’Connor CM, Henry T, Taussig A, et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. American Heart Journal, October 2011. Volume 162, Number 4, 654-662. DOI: http://dx.doi.org/10.1016/j.ahj.2011.07.020.

Read More

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia

Powell RJ, Comerota AJ, Berceli SA, Guzman R, Henry TD, Tzeng E, Velazquez O, Marston WA, Bartel RL, Longcore A, Stern T, Watling S. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. Journal of…

Read More